Interaction of orally administered metoprolol, practolol and propranolol with isoprenaline in asthmatics

  • G. Thiringer
  • N. Svedmyr


In a single-blind study eight patients with asthma received on five different days, in randomized order, doses of: propranolol 40 mg, metoprolol 50 mg and 100 mg (a new selective beta1-blocking agent with no intrinsic activity), practolol 200 mg or placebo. The beta1-blocking potency of the selective drugs at these dose levels was higher than or equal to that of propranolol. The effects on heart rate, blood pressure, ventilatory capacity (FEV1) and skeletal muscle tremor were studied at rest and during infusion of increasing doses of isoprenaline. There was a slight decrease in FEV1 after propranolol and both doses of metoprolol. After the placebo, isoprenaline produced a dose-dependent increase in heart rate, systolic blood pressure, FEV1 and tremor, and lowered the diastolic blood pressure. Propranolol almost completely blocked the effects of all doses of isoprenaline on heart rate, FEV1 and tremor, and, to a lesser extent, any change in systolic and diastolic pressure. The two doses of metoprolol and practolol did not inhibit the effect of isoprenaline on FEV1. The effect of metoprolol and practolol on the isoprenaline-induced increase of heart rate indicated their selectivity for beta1-receptors. The increase in tremor during infusion of isoprenaline was blocked by propranolol, but not by the selective beta1-blockers, which implies that the induction of tremor was a beta2-effect. The effect of isoprenaline on FEV1 was not inhibited by selective beta1-blocking agents, and so, when combined with beta2-stimulators, they may be given to asthmatic patients.

Key words

Metoprolol practolol propranolol isoprenaline dose-response-curves interaction ventilatory function asthma 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Atsmon, A., Blum, J., Steiner, M., Latz, A., Wijsenbeek, H.: Further studies with propranolol in psychotic patients. Relation to initial psychiatric state, urinary catecholamines and 3-methoxy-4-hydroxyphenylglycol excretion. Psychopharmacologia (Berl.)27, 249–254 (1972)Google Scholar
  2. Bengtsson, C.: The effect of metoprolol. A new selective adrenergic beta1-receptor blocking agent — in mild hypertension. Acta. med. scand.199, 65 (1976)Google Scholar
  3. Bernecker, C., Roetscher, J.: The beta-blocking effect of practolol in asthmatics. Lancet1970 II, 662Google Scholar
  4. Beumer, H.M.: Adverse effects of beta-adrenergic receptor blocking drugs on respiratory function. Drugs7, 130–138 (1974)Google Scholar
  5. Beumer, H.M., Hardonk, H.J.: Effects of beta-adrenergic blocking drugs on ventilatory function in asthmatics. Europ. J. clin. Pharmacol.5, 77–80 (1972)Google Scholar
  6. Brown, P., Baddeley, H., Read, A.E., Davies, J.D., McGarry, J.: Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (Practolol). Lancet1974 II, 1477–1481Google Scholar
  7. Carlsson, E., Åblad, B., Brändström, A., Carlsson, B.: Differentiated blockade of the chronotropic effects of various adrenergic stimuli in the cat heart. Life Sci.11, 953–958 (1972)Google Scholar
  8. Colquhoun, D.: Lectures on biostatistics. Oxford 1971Google Scholar
  9. Felix, R.H., Ive, F.A., Dahl, M.G.C.: Cutaneous and ocular reactions to practolol. Brit. med. J.1974 IV, 321–324Google Scholar
  10. Johnsson, G.: Influence of metoprolol and propranolol on hemodynamic effects induced by adrenaline and physical work. Acta pharmacol. (Kbh.)36, 59–68 (Suppl. 5) (1975)Google Scholar
  11. Johnsson, G., Nyberg, G., Sölvell, L.: Influence of metoprolol and propranolol on hemodynamic effects induced by physical work and isoprenaline. Acta pharmacol. (Kbh.)36, 69–75 (Suppl. 5) (1975)Google Scholar
  12. Johnsson, G., Svedmyr, N., Thiringer, G.: Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function, heart rate and blood pressure in asthmatics. Europ. J. clin. Pharmacol.8, 175–180 (1975)Google Scholar
  13. Keyriläinen, O., Uusitalo, A.: Effects of long-term treatment with metoprolol in angina pectoris. Acta. med. scand. In press.Google Scholar
  14. Klein, W.W.: Vergleichende Untersuchungen über die Wirkung verschiedener beta-Rezeptoren-Blocker auf die Lungenfunktion bei Gesunden und Patienten mit obstruktiven Atemwegserkrankungen. Wien. Z. inn. Med.52, 507–511 (1971)Google Scholar
  15. Kram, J., Bourne, H.R., Melmon, K.L., Maibach, H.: Propranolol. Ann. intern. med.80, 282 (1974)Google Scholar
  16. Kumana, C.R., Kaye, C.M.: An investigation of the relationship between beta-adrenoceptor blockade and plasma practolol concentration in man. Europ. J. clin. Pharmacol.7, 243–248 (1974)Google Scholar
  17. Lands, A.M., Luduena, F.P., Buzzo, H.J.: Differentiation of receptors responsive to isoproterenol. Life Sci.6, 2241–2249 (1967)Google Scholar
  18. Larsson, S., Svedmyr, N.: Studies of muscle tremor induced by beta-adrenostimulating drugs. Scand. J. resp. Dis.,Suppl. 88, 54 (1974)Google Scholar
  19. MacDonald, A.G., Ingram, C.G., McNeill, R.S.: The effect of propranolol on airway resistance. Brit. J. Anaesth.39, 919 (1967)Google Scholar
  20. McNeill, R.S.: Effect of a beta-adrenergic-blocking agent, propranolol, on asthmatics. Lancet1964 II, 1101–1102Google Scholar
  21. Sowton, E., Das Gupta, D.S., Baker, I.: Comparative effects of beta-adrenergic blocking drugs. Thorax30, 9–18 (1975)Google Scholar
  22. Sörenby, L.: Inhibition of the antigen-induced release of histamine from guinea-pig lung by terbutaline. Acta pharmacol.34, 267–272 (1974)Google Scholar
  23. Svedmyr, N., Larsson, S., Thiringer, G.: Studies in asthmatics on the development of “resistance” to long-acting adrenergic beta-stimulators. Chest.69, 479 (1976)Google Scholar
  24. Thiringer, G., Svedmyr, N.: Comparison of infused and inhaled terbutaline in patients with asthma. Scand. J. resp. Dis.57, 17–24 (1976)Google Scholar
  25. Thiringer, G., Svedmyr, N.: Evaluation of skeletal muscle tremor due to bronchodilator agents. Scand. J. resp. Dis.56, 93–102 (1975)Google Scholar
  26. Thiringer, G., Svedmyr, N.: The effects of selective and non-selective beta-blocking agents in patients with asthma. Proceedings of the 12th International Congress of Internal Medicine, Tel Aviv. Basel: Karger 1975Google Scholar
  27. Waal, Manning, H.J., Simpson, F.O.: Practolol treatment in asthmatics. Lancet1971 II, 1264–1265Google Scholar
  28. Åblad, B., Carlsson, B., Carlsson, E., Dahlöf, C., Ek, L., Hultberg, E.: Cardiac effects of beta-adrenergic receptor antagonists. Adv. Cardiol.12, 290–302 (1974Google Scholar

Copyright information

© Springer-Verlag 1976

Authors and Affiliations

  • G. Thiringer
    • 1
  • N. Svedmyr
    • 1
  1. 1.Clinical Pharmacology LaboratoryUniversity Lung Clinic, Renströmska HospitalGöteborgSweden

Personalised recommendations